Heart Center Department, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia.
Department of Medicine, Wayne State University, Detroit, MI, USA.
Angiology. 2020 Sep;71(8):721-725. doi: 10.1177/0003319720927239. Epub 2020 May 20.
We report the prevalence of coronary artery disease (CAD) in asymptomatic patients with end-stage kidney disease (ESKD) on hemodialysis and explore the best revascularization strategies prior to kidney transplantation. This is a retrospective single-center study, which included all patients who were candidates for kidney transplantation and underwent coronary angiography between 2003 and 2018. All included patients underwent coronary angiography without noninvasive testing and were asymptomatic cardiac-wise. Out of the 368 patients with ESRD, 45% had coronary vessel disease, 17% had 3-vessel disease, 11% had 2-vessel disease, 5.2% had significant left main artery narrowing, and 17% had single-vessel disease. Patients with 3-vessel disease had the worst survival rate at 5 and 10 years. The patients with significant 3-vessel disease or left main artery involvement underwent revascularization; 19% underwent coronary artery bypass grafting, 5% had stenting of the coronary arteries, and 4.7% were on maximal medical therapy. The patients who underwent stenting had a better survival than those on medical therapy, but the difference was not significant ( = .445). Our findings reflect a high prevalence of CAD in patients with ESKD. There is a need for further studies to evaluate benefits of cardiovascular screening in this patient population.
我们报告了在接受血液透析的终末期肾病(ESKD)无症状患者中心血管疾病(CAD)的患病率,并探讨了在进行肾移植之前的最佳血运重建策略。这是一项回顾性单中心研究,纳入了所有 2003 年至 2018 年期间进行过冠状动脉造影且适合进行肾移植的患者。所有纳入的患者均在未进行无创检查且在心脏方面无症状的情况下进行了冠状动脉造影。在 368 名 ESRD 患者中,45%存在冠状动脉血管疾病,17%存在 3 支血管疾病,11%存在 2 支血管疾病,5.2%存在显著左主干狭窄,17%存在单支血管疾病。患有 3 支血管疾病的患者在 5 年和 10 年的生存率最差。存在严重 3 支血管疾病或左主干受累的患者进行了血运重建;19%接受了冠状动脉旁路移植术,5%接受了冠状动脉支架置入术,4.7%接受了最大程度的药物治疗。接受支架置入术的患者的生存率优于接受药物治疗的患者,但差异无统计学意义(=.445)。我们的研究结果反映了 ESKD 患者 CAD 的高患病率。需要进一步的研究来评估在该患者群体中进行心血管筛查的获益。